It’s generally thought that the more critical a gene is to cellular function, the more…
emcguinnNovember 19, 2020
Receptor Life Sciences announced today that the Company was granted a Schedule I research license…
emcguinnNovember 18, 2020
‘As Good as It Gets’: Moderna’s COVID-19 Vaccine, Which Got Its Start in Seattle, Is 94.5% Effective
Biotech giant Moderna on Monday announced that its COVID-19 vaccine was 94.5% effective in preventing the disease…
emcguinnNovember 18, 2020
WRF Postdoctoral Fellows are funded for three years at eligible institutions in Washington state to…
emcguinnNovember 18, 2020
Fred Hutchinson Cancer Research Center is starting volunteer enrollment for a COVID-19 vaccine trial. The phase…
emcguinnNovember 17, 2020
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of…
emcguinnNovember 16, 2020
A new lens on visual neurons is laying the groundwork for a more complete “family…
emcguinnNovember 13, 2020
A Seattle-based biotech company is working on a new way to identify people who have…
emcguinnNovember 13, 2020
Drug delivery is a recurring conundrum in cancer treatment. Scientists have developed many anti-cancer therapeutics.…
emcguinnNovember 10, 2020
